Chief Technology Officer
KI
Kaigene, Inc
The startup develops therapeutic antibodies targeting the underlying mechanisms of rare autoimmune diseases, providing safe and effective treatment options. By addressing significant clinical unmet needs, their products aim to enhance patient quality of life through improved disease management.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$7.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops therapeutic antibodies targeting the underlying mechanisms of rare autoimmune diseases, providing safe and effective treatment options. By addressing significant clinical unmet needs, their products aim to enhance patient quality of life through improved disease management.